Choose MarShield for Radiation Shielding Solutions in Nuclear Medicine - October 2022

According to Grand View Research, the global nuclear medicine market size was an estimated 8.1 billion USD in 2021 and is expected to increase 13% from 2022-2030. Nuclear medicine is expanding quickly due to advancements in products and government initiatives that improve nuclear medicine access. There is also an increase in cancer patients that will contribute to market growth.

Radiopharmaceuticals are radioactive drugs that are made, studied, and administered in a variety of settings, including hospitals, universities, and research centres. Shielding is increasingly in demand as nuclear medicine becomes more and more common. The nuclear medicine sector has access to a wide range of shielding products